GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanobiotix SA (LTS:0QAV) » Definitions » PS Ratio

Nanobiotix (LTS:0QAV) PS Ratio : 3.71 (As of Dec. 12, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Nanobiotix PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Nanobiotix's share price is €3.354. Nanobiotix's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was €0.91. Hence, Nanobiotix's PS Ratio for today is 3.71.

Good Sign:

Nanobiotix SA stock PS Ratio (=4.04) is close to 10-year low of 3.66

The historical rank and industry rank for Nanobiotix's PS Ratio or its related term are showing as below:

LTS:0QAV' s PS Ratio Range Over the Past 10 Years
Min: 3.64   Med: 1159.29   Max: 7790
Current: 3.64

During the past 13 years, Nanobiotix's highest PS Ratio was 7790.00. The lowest was 3.64. And the median was 1159.29.

LTS:0QAV's PS Ratio is ranked better than
74.78% of 1015 companies
in the Biotechnology industry
Industry Median: 8.73 vs LTS:0QAV: 3.64

Nanobiotix's Revenue per Sharefor the six months ended in Jun. 2024 was €0.13. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was €0.91.

During the past 3 years, the average Revenue per Share Growth Rate was 641.10% per year.

During the past 13 years, Nanobiotix's highest 3-Year average Revenue per Share Growth Rate was 641.10% per year. The lowest was -69.10% per year. And the median was -27.80% per year.

Back to Basics: PS Ratio


Nanobiotix PS Ratio Historical Data

The historical data trend for Nanobiotix's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanobiotix PS Ratio Chart

Nanobiotix Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,760.00 6,900.00 - - 8.16

Nanobiotix Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 8.16 -

Competitive Comparison of Nanobiotix's PS Ratio

For the Biotechnology subindustry, Nanobiotix's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanobiotix's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanobiotix's PS Ratio distribution charts can be found below:

* The bar in red indicates where Nanobiotix's PS Ratio falls into.



Nanobiotix PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Nanobiotix's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=3.354/0.905
=3.71

Nanobiotix's Share Price of today is €3.354.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nanobiotix's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was €0.91.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Nanobiotix  (LTS:0QAV) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Nanobiotix PS Ratio Related Terms

Thank you for viewing the detailed overview of Nanobiotix's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanobiotix Business Description

Traded in Other Exchanges
Address
60 Rue de Wattignies, Paris, FRA, 75012
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Nanobiotix Headlines

No Headlines